MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

BIO-TECHNE Corp Company Profile (NASDAQ:TECH)

Consensus Ratings for BIO-TECHNE Corp (NASDAQ:TECH) (?)
Ratings Breakdown: 2 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.60)
Consensus Price Target: $108.75 (2.43% downside)

Analysts' Ratings History for BIO-TECHNE Corp (NASDAQ:TECH)
Show:
DateFirmActionRatingPrice TargetActions
5/5/2016Leerink SwannReiterated RatingHold$105.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/3/2016Janney Montgomery ScottUpgradeNeutral -> Buy$100.00 -> $118.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/3/2016Robert W. BairdBoost Price TargetOutperform$100.00 -> $102.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/2/2015Craig HallumLower Price TargetBuy$125.00 -> $110.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/29/2015StephensDowngradeOverweight -> Equal WeightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/26/2014 forward)
Earnings History for BIO-TECHNE Corp (NASDAQ:TECH)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/4/2016        
5/3/2016Q316$0.89$1.01$122.65 million$131.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/2/2016Q216$0.82$0.88$118.59 million$120.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/28/2015Q1$0.85$0.79$116.91 million$12.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015Q415$0.86$0.87$116.85 million$117.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2015Q315$0.91$0.86$119.30 million$114.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/3/2015Q215$0.86$0.89$112.73 million$111.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/28/2014Q115$0.87$0.85$108.65 million$108.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/11/2014Q414$0.85$0.88$91.80 million$92.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/28/2014Q314$0.89$0.94$92.50 million$95.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/4/2014Q214$0.80$0.75$84.79 million$84.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2013Q114$0.80$0.83$82.36 million$85.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2013Q4 2013$0.83$0.82$79.71 million$79.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2013Q3 2013$0.90$0.88$84.00 million$81.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/5/2013Q2 2013$0.77$0.74$76.40 million$75.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/23/2012$0.79$0.75ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/31/2012$0.85$0.80ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2012$0.89$0.90ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/31/2012$0.79$0.76ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/25/2011$0.84$0.81ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/2/2011$0.76$0.76ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/3/2011$0.80$0.84ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/1/2011$0.68$0.71ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for BIO-TECHNE Corp (NASDAQ:TECH)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164$0.86$0.92$0.90
Q2 20163$0.88$0.94$0.92
Q3 20161$0.82$0.82$0.82
Q4 20163$0.85$0.95$0.91
Q1 20173$0.78$0.96$0.85
Q2 20173$0.85$1.01$0.91
Q3 20172$0.96$1.00$0.98
Q4 20172$0.93$0.96$0.95
(Data provided by Zacks Investment Research)
Dividend History for BIO-TECHNE Corp (NASDAQ:TECH)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
5/3/2016quarterly$0.321.27%5/11/20165/13/20165/27/2016Tweet This Announcement  Share This Announcement on StockTwits
2/2/2016quarterly$0.321.48%2/10/20162/12/20162/26/2016Tweet This Announcement  Share This Announcement on StockTwits
10/29/2015quarterly$0.321.45%11/10/201511/13/201511/27/2015Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015quarterly$0.321.18%8/13/20158/17/20158/28/2015Tweet This Announcement  Share This Announcement on StockTwits
5/5/2015quarterly$0.321.31%5/11/20155/15/20155/29/2015Tweet This Announcement  Share This Announcement on StockTwits
2/3/2015quarterly$0.321.4%2/11/20152/13/20152/27/2015Tweet This Announcement  Share This Announcement on StockTwits
10/30/2014quarterly$0.321.41%11/6/201411/10/201411/24/2014Tweet This Announcement  Share This Announcement on StockTwits
8/11/2014quarterly$0.311.31%8/19/20148/21/20148/29/2014Tweet This Announcement  Share This Announcement on StockTwits
4/28/2014quarterly$0.311.37%5/7/20145/9/20145/23/2014Tweet This Announcement  Share This Announcement on StockTwits
2/4/2014quarterly$0.311.48%2/12/20142/14/20142/28/2014Tweet This Announcement  Share This Announcement on StockTwits
10/31/2013quarterly$0.311.4%11/7/201311/12/201311/25/2013Tweet This Announcement  Share This Announcement on StockTwits
8/6/2013quarterly$0.301.62%8/14/20138/16/20138/31/2013Tweet This Announcement  Share This Announcement on StockTwits
4/30/2013quarterly$0.301.86%5/8/20135/10/20135/24/2013Tweet This Announcement  Share This Announcement on StockTwits
2/5/2013quarterly$0.301.74%2/13/20132/15/20133/1/2013Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)
Insider Trading History for BIO-TECHNE Corp (NASDAQ:TECH)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/15/2016Roger C LucasDirectorSell100$112.15$11,215.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/18/2016Roger C LucasDirectorSell100$102.53$10,253.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/9/2016Charles A DinarelloDirectorSell5,000$101.91$509,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/6/2016Roger C LucasDirectorSell500$100.24$50,120.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/20/2016Roger C LucasDirectorSell100$92.40$9,240.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/16/2016Roger C LucasDirectorSell100$92.90$9,290.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/5/2016Roger C. LucasDirectorSell5,000$83.68$418,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2015Roger C LucasDirectorSell5,000$106.01$530,050.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/8/2015Randolph C SteerDirectorSell1,000$99.39$99,390.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/19/2015Howard V OconnellDirectorSell5,000$95.78$478,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/10/2014Karen A HolbrookDirectorSell1,000$92.40$92,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2014Kevin J ReaganVPSell3,591$89.35$320,855.85View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/8/2014Charles A DinarelloDirectorSell3,000$90.44$271,320.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2014Karen A HolbrookDirectorSell5,000$95.54$477,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/7/2014Howard OconnellDirectorSell5,000$91.00$455,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/4/2014Karen HolbrookDirectorSell5,000$89.83$449,150.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/27/2014Randolph SteerDirectorSell5,000$88.78$443,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/13/2013Randolph SteerDirectorSell15,000$86.20$1,293,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/8/2013Robert BaumgartnerDirectorSell10,000$87.00$870,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/4/2013Roger C LucasDirectorSell10,000$87.64$876,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/6/2013Howard V OconnellDirectorBuy2,361$65.00$153,465.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for BIO-TECHNE Corp (NASDAQ:TECH)
DateHeadline
06/26/16 08:58 AMCEO One on One: Matthew F. Rice, managing director, Bionostics Inc., Devens
06/25/16 06:06 PMBio Techne Corporation (NASDAQ:TECH) Short Interest Decreased By 4.47% - Press Telegraph
06/25/16 06:06 PMStock Performance Focus on: Bio-Techne Corp. (NASDAQ:TECH) - Press Telegraph
06/24/16 06:48 PMBio-Techne Corp (NASDAQ:TECH) Brokerage Rating Update - Investor Newswire
06/24/16 09:18 AMCovering the Bases on Bio-Techne Corp (NASDAQ:TECH): Where is the Stock Going? - Press Telegraph
06/23/16 07:29 PMEquity Research and Technical Review on Bio-Techne Corp (NASDAQ:TECH) - Press Telegraph
06/16/16 11:15 AMBIO TECHNE : B-MoGen completes Sereis A Financing
06/07/16 07:00 PMWhat Is Mean Rating On Bio-Techne Corp (NASDAQ:TECH)? - Stocks Daily
06/03/16 02:44 PMETF’s with exposure to Bio-Techne Corp. : June 3, 2016 -
05/04/16 06:22 AMBio-Techne Announces Access to B-MoGen Biotechnologies' Gene Editing Technology - Bio-Techne Corporation (NASDAQ: TECH) and B-MoGen Biotechnologies, Inc. announced today that Bio-Techne has made a seed investment in B-MoGen and the parties have entered into collaboration agreement which gives Bio-Techne access to gene editing technology. Bio-Techne B-MoGen is a University of Minnesota spin-off founded by David Largaespada and Branden Moriarity, two faculty from the Masonic Cancer Center who have a stellar track record in deploying cutting-edge methods for gene editing and delivery, in the search for novel cancer biomarkers and therapeutics. The startup plans to commercialize these proprietary molecular tools, and provide innovative services to drive research and discovery in the new CRISPR age. The explosion of interest in gene and genome editing using the CRISPR-Cas9 system is fueling improvements to the basic CRISPR molecular toolkit that allow remarkably precise and complex manipulations of multi-gene activity, and B-MoGen is actively participating in this field with a raft of new methods that speed CRISPR genome editing and genetically modify cells. In particular, B-MoGen has filed for patent coverage for ...Full story available on Benzinga.com
05/04/16 06:22 AMBio-Techne Gets Access To B-MoGen Biotechnologies' Gene Editing Technology - Bio-Techne Corporation (NASDAQ: TECH) and B-MoGen Biotechnologies, Inc. disclosed that Bio-Techne has made a seed investment in B-MoGen. The two have also have also struck a deal by which Bio-Techne would get access to gene editing technology. Bio-Techne's CTO, Fernando Bazan, commented, "B-MoGen is a terrific investment in an emerging field of novel molecular and discovery tools that not only drives new science at a dizzying pace, but also provides a strong technological foundation ...Full story available on Benzinga.com
05/04/16 05:45 AMBRIEF-Bio-Techne acquires access to B-Mogen Biotechnologies' gene editing technology - * Bio-Techne corporation acquires access to b-mogen biotechnologies' gene editing technology
03/15/16 01:23 PMTraders Are Watching: Net Element International Inc (NASDAQ:NETE), Bio-Techne (NASDAQ:TECH), Synergy ... - KC Register - Traders Are Watching: Net Element International Inc (NASDAQ:NETE), Bio-Techne (NASDAQ:TECH), Synergy ...KC RegisterBio-Techne Corp. (NASDAQ:TECH) was upgraded by stock analysts at TheStreet from a “hold” rating to a “buy” rating in a note issued to investors report. In other BIO-TECHNE Corp news, Director Roger C. Lucas sold 5,000 shares of the company's stock in a ...
03/01/16 07:31 AMBio-Techne Corp. breached its 50 day moving average in a Bearish Manner : TECH-US : March 1, 2016 -
02/28/16 01:48 PMBio-Techne Corp. (TECH) - Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells biotechnology reagents, instruments, and clinical diagnostic products worldwide. The company operates through three segments: Biotechnology, Clinical Controls, and ...
02/26/16 09:04 AMHow Many BIO-TECHNE Corp (NASDAQ:TECH)'s Analysts Are Bullish? - Business Standard Tribune - How Many BIO-TECHNE Corp (NASDAQ:TECH)'s Analysts Are Bullish?Business Standard TribuneOut of 5 analysts covering BIO-TECHNE Corp (NASDAQ:TECH), 3 rate it “Buy”, 0 “Sell”, while 3 “Hold”. This means 50% are positive. BIO-TECHNE Corp was the topic in 6 analyst reports since August 18, 2015 according to StockzIntelligence Inc. Below is a ...Techne Corporation (NASDAQ:TECH) New Analyst RatingsShare Trading Newsall 2 news articles »
02/19/16 01:53 PMBio Techne Corporation (NASDAQ:TECH) Sellers Covered 4.28% of Their Shorts - Business Standard Tribune - Bio Techne Corporation (NASDAQ:TECH) Sellers Covered 4.28% of Their ShortsBusiness Standard TribuneThe stock of Bio Techne Corporation (NASDAQ:TECH) registered a decrease of 4.28% in short interest. TECH's total short interest was 2.17 million shares in February as published by FINRA. Its down 4.28% from 2.27 million shares, reported previously.
02/13/16 12:54 PMBio Techne Corporation (NASDAQ:TECH) Sellers Covered 4.28% of Their Shorts - fdanewsalert.com - Bio Techne Corporation (NASDAQ:TECH) Sellers Covered 4.28% of Their Shortsfdanewsalert.comThe stock of Bio Techne Corporation (NASDAQ:TECH) registered a decrease of 4.28% in short interest. TECH's total short interest was 2.17M shares in February as published by FINRA. Its down 4.28% from 2.27 million shares, reported previously.Bio-Techne Corp (NASDAQ:TECH): Favorite PickStocks Dailyall 2 news articles »
02/10/16 12:53 PMBio-Techne Corp (TECH) Ex-Dividend Date Scheduled for February 10, 2016 - Nasdaq - Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for February 10, 2016Nasdaqwill begin trading ex-dividend on February 10, 2016. A cash dividend payment of $0.32 per share is scheduled to be paid on February 26, 2016. Shareholders who purchased TECH prior to the ex-dividend date are eligible for the cash dividend payment.Is BIO-TECHNE Corp (NASDAQ:TECH) Stock a Sell after Roger Lucas's Insider Trading?fdanewsalert.comBIO-TECHNE Corp (TECH) to Issue Quarterly Dividend of $0.32 on February 26thFinancial Market NewsBio-Techne Corp (NASDAQ:TECH) Analyst Ratings and Target UpdateUptick AnalystIntercooler Financial -Street Edition -Equities Focusall 8 news articles »
02/09/16 01:52 PMBio-Techne Corp. – Value Analysis (NASDAQ:TECH) : February 9, 2016 -
02/09/16 12:20 PMDividend News: Otter Tail Corporation (NASDAQ:OTTR), BIO-TECHNE Corp (NASDAQ:TECH) and Eli Lilly and Co ... - Sonoran Weekly Review - Sonoran Weekly ReviewDividend News: Otter Tail Corporation (NASDAQ:OTTR), BIO-TECHNE Corp (NASDAQ:TECH) and Eli Lilly and Co ...Sonoran Weekly ReviewOtter Tail Corporation (NASDAQ:OTTR) intends to pay a quarterly dividend of $0.3125 per share on March 10, 2016. The dividend will captured investors who get into the stock before Feb. 10, 2016. As a percentage of the recent stock price, Otter's ...and more »
02/09/16 07:11 AMBio-Techne Corp. breached its 50 day moving average in a Bearish Manner : February 9, 2016 -
02/08/16 11:07 AMEx-Dividend Reminder: Otter Tail, Bio-Techne and Eli Lilly - Looking at the universe of stocks we cover at Dividend Channel, on 2/10/16, Otter Tail Corp. (NASD: OTTR), Bio-Techne Corp (NASD: TECH), and Eli Lilly & Co. (NYSE: LLY) will all trade ex-dividend for their respective upcoming dividends. Otter Tail Corp. will pay its quarterly dividend of $0.3125 on 3/10/16, Bio-Techne Corp will pay its quarterly dividend of $0.32 on 2/26/16, and Eli Lilly & Co. will pay its quarterly dividend of $0.51 on 3/10/16.
02/07/16 11:37 AMBio Techne Corporation (NASDAQ:TECH) Sellers Increased By 3.15% Their Shorts - fdanewsalert.com - Bio Techne Corporation (NASDAQ:TECH) Sellers Increased By 3.15% Their Shortsfdanewsalert.comThe stock of Bio Techne Corporation (NASDAQ:TECH) registered an increase of 3.15% in short interest. TECH's total short interest was 2.27M shares in February as published by FINRA. Its up 3.15% from 2.20M shares, reported previously. With 314,400 ...BIO-TECHNE Corp (TECH) PT Raised to $102.00 at Robert W. BairdIntercooler FinancialToday BIO-TECHNE Corp Stock RisesSonoran Weekly Reviewall 4 news articles »
02/03/16 06:49 PMBio-Techne's (TECH) CEO Chuck Kummeth on Q2 2016 Results - Earnings Call Transcript - Tables reconciling these measures to most comparable GAAP measures are available in the company's press release issued early this morning or on the Bio-Techne Corporation website, at www.biotechne.com. And with that, I will turn the call over to Chuck.
02/03/16 11:33 AMBio-Techne (TECH) Q2 Earnings Match, Sales Beat Estimates - Bio-Techne Corp. (TECH - Snapshot Report) reported adjusted earnings of 82 cents per share (including stock-based compensation) in the second quarter of fiscal 2016, in line with the Zacks Consensus Estimate and flat on a year-over-year basis. Excluding ...
02/02/16 11:39 AMBio-Techne Corp. Bottom Line Climbs 3% In Q2 - Bio-Techne Corp. (TECH) revealed a profit for its second quarter that advanced compared to the same period last year. The company said its bottom line came in at $32.83 million, or $0.88 per share. This was up from $31.77 million, or $0.85 per share, in ...
02/02/16 08:02 AMBIO-TECHNE CORP Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements -
02/02/16 06:21 AMTechne declares $0.32 dividend -
02/02/16 06:07 AMQ2 2016 Bio-Techne Corp Earnings Release - Before Market Open -
02/02/16 06:00 AMBio-Techne Releases Second Quarter Fiscal 2016 Results - [PR Newswire] - MINNEAPOLIS, Feb. 2, 2016 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the second quarter ended December 31, 2015. Second Quarter 2016 Highlights Second ...
02/01/16 06:45 PMEarnings Recap: BIO-TECHNE Corp (TECH) - CWRU Observer - Earnings Recap: BIO-TECHNE Corp (TECH)CWRU ObserverBIO-TECHNE Corp (NASDAQ:TECH) is expected to report 2nd quarter earnings before the open on Tuesday, Feb 2, 2016, with a conference call scheduled for 9:00AM EST. Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and ...BIO-TECHNE Corp (TECH) to Release Earnings on TuesdayEMQBIO-TECHNE Corp (TECH) Scheduled to Post Earnings on TuesdayCorvus Business NewswireAnticipated Earnings Per Share Increase for BIO-TECHNE Corp (TECH)OctaFinance.comZolmax -Market Briefingall 6 news articles »
01/29/16 03:30 PMProteinSimple Unveils the New Single Analyte Cartridge for Simple Plex™ - [PR Newswire] - SANTA CLARA, Calif., Jan. 29, 2016 /PRNewswire/ -- ProteinSimple announced today an expansion of the Simple Plex™ immunoassay offering by launching a new single analyte cartridge for the analysis of 72 samples at once. This new cartridge enables Simple Plex users to run 72 samples in an hour with triplicate results. It is powered by R&D Systems® reagents, the expert in immunoassays. Simple Plex cartridge-based immunoassays have the same specificity of a single-plex ELISA, only with sub-picogram/ml detection limits, and highly sensitive results at lower sample volumes. Moreover, Simple Plex offers better precision and greater dynamic range at 4-5 logs than traditional ELISAs.
01/28/16 06:26 PMBio-Techne Corp (NASDAQ:TECH) Short Interest Update - The Daily Rover - Bio-Techne Corp (NASDAQ:TECH) Short Interest UpdateThe Daily RoverThe short interest in Bio-Techne Corp (NASDAQ:TECH) has increased from 2,198,376 on December 31,2015 to 2,267,705 on January 15,2016. The change was measured at 69,329 shares or 3.2%. The leftover shorts were 6.2% of the floated shares.
01/26/16 11:38 AMBio-Techne Corp Analyst Rating Update - Market Briefing - Bio-Techne Corp Analyst Rating UpdateMarket BriefingBio-Techne Corp (NASDAQ:TECH) has received a hold rating for the short term, according to the latest rank of 3 from research firm, Zacks Investment Research. The company received an average rating of 1.8 from 5 analysts. 3 have rated it as a strong buy.and more »
01/26/16 07:30 AMProteinSimple® Recharges iCE - [PR Newswire] - SAN JOSE, Calif., Jan. 26, 2016 /PRNewswire/ -- ProteinSimple®, the Protein Platforms division of Bio-Techne, today announced the launch of its advanced capillary electrophoresis system, Maurice™. The new platform is an expansion of iCE product line for imaged capillary electrophoresis for the quantitative analysis of Identity, Purity, and Heterogeneity profiles of bio-pharmaceuticals. This technology is the heart of Maurice, delivering the same high resolution performance with even shorter run times. Beyond that, an added native fluorescence detection mode allows for higher sensitivity.
01/25/16 05:56 PMBio-Techne Corp (NASDAQ:TECH) - Stock Sentiment And ABR Update - Investor Newswire - Bio-Techne Corp (NASDAQ:TECH) - Stock Sentiment And ABR UpdateInvestor NewswireZacks Research has given an average broker rating of 1.8 to Bio-Techne Corp (NASDAQ:TECH)'s shares. Zacks assigns a simplified score in between one and five against the complex analysts' ratings. A score towards 1-2 typically means a consensus Buy, ...and more »
01/25/16 10:49 AMCompany Shares of Bio-Techne Corp (NASDAQ:TECH) Rally 3.06% - WallStreet Prudent - Company Shares of Bio-Techne Corp (NASDAQ:TECH) Rally 3.06%WallStreet PrudentShares of Bio-Techne Corp (NASDAQ:TECH) appreciated by 3.06% during the past week but lost 5.85% on a 4-week basis. In the past week, the shares have outperformed the S&P 500 by 1.62% and the outperformance increases to 1.75% for the last 4 ...
01/21/16 05:48 PMBio-Techne Corp (NASDAQ:TECH): Stock in the spotlight - Stocks Daily - Bio-Techne Corp (NASDAQ:TECH): Stock in the spotlightStocks DailySell-side analysts maintain a positive outlook on the shares of Bio-Techne Corp (NASDAQ:TECH). Based on the poll results published by the Zacks Research, the stock of the company has been assigned a 1.8 rating. This number represents the scoring on a ...and more »
01/17/16 07:16 PMIs bitcoin broken? Prominent developer cashes out - MarketWatch - MarketWatchIs bitcoin broken? Prominent developer cashes outMarketWatchA prominent bitcoin developer has labeled the currency a failed experiment, widening the rift over an arcane but critical technical issue that has divided the community for nearly a year. “The fundamentals are broken, and whatever happens to the price ...Bitcoin Developer Sparks Debate About Future Growth Of CryptocurrencyInternational Business TimesLead developer quits bitcoin saying it "has failed"Stuff.co.nzHigh-profile developer declares Bitcoin doomed, leaves currency projectExtremeTechnewsBTC -Newsweekall 113 news articles »
01/12/16 03:45 PMBio-Techne to Host Conference Call on February 2, 2016 to Announce Second Quarter Financial Results - [at noodls] - Minneapolis/January 12, 2016/ Bio-Techne Corporation (NASDAQ:TECH) today announced that management will host a conference call on Tuesday, February 2, 2016, at 8:00 a.m. CST to review second quarter fiscal ...
01/12/16 10:16 AM11:16 am Lagging sectors -
12/30/15 07:46 AMBIO-TECHNE CORP Files SEC form 8-K, Change in Directors or Principal Officers -
12/25/15 07:10 AMBio-Techne Corp. breached its 50 day moving average in a Bullish Manner : December 25, 2015 -
12/10/15 09:07 AMBio-Techne Corp. breached its 50 day moving average in a Bearish Manner : December 10, 2015 -
12/08/15 12:17 PMBIO-TECHNE CORP Financials -
11/30/15 07:16 AMBio-Techne Corp. breached its 50 day moving average in a Bullish Manner : November 30, 2015 -
11/09/15 03:03 PMBIO-TECHNE CORP Files SEC form 10-Q, Quarterly Report -
11/05/15 09:10 AMBio-Techne Declares Dividend - [at noodls] - Minneapolis/October 28, 2015/ -- Bio-Techne Corporation (NASDAQ:TECH) announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended September 30, 2015. The ...
10/30/15 03:03 PMBIO-TECHNE CORP Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of Sec -
About BIO-TECHNE Corp

BIO-TECHNE Corp logoBio-Techne Corporation (Bio-Techne), formerly Techne Corporation, develops, manufactures and sells biotechnology reagents, instruments and clinical diagnostic products around the world. The Company has three business segments: the Biotechnology, Clinical Controls and Protein Platforms divisions. The Biotechnology segment develops, manufactures and sells biotechnology research and diagnostic products around the world. The Clinical Controls segment develops and manufactures controls and calibrators for the global clinical market. The Protein Platforms segment develops and commercializes systems and consumables for protein analysis. Bio-Techne is engaged in providing specialized proteins, including cytokines and growth factors, antibodies, related immunoassays, biologically active small molecules, and other reagents to the research, diagnostics and clinical controls markets.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: Life Sciences Tools & Services
  • Exchange: NASDAQ
  • Symbol: TECH
  • CUSIP: 87837710
Key Metrics:
  • Previous Close: $112.74
  • 50 Day Moving Average: $108.22
  • 200 Day Moving Average: $94.53
  • P/E Ratio: 39.67
  • P/E Growth: 2.48
  • Market Cap: $4.15B
  • Current Quarter EPS Consensus Estimate: $3.64 EPS
Additional Links:
BIO-TECHNE Corp (NASDAQ:TECH) Chart for Sunday, June, 26, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha